PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Evolution of the Therapeutic Care in Ovarian Cancer From 2011
- Status
- SUSPENDED
- Phase
- N/A
HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
- Status
- RECRUITING
- Phase
- PHASE2
Trial in Patients With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Shorter Scalp Cooling Time in Paclitaxel
- Status
- COMPLETED
- Phase
- NA
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA
- Status
- COMPLETED
- Phase
- N/A
Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
Primary Debulking Surgery Including Bowel Resection in Advanced Stage Ovarian Cancer Using Caiman® Technology
- Status
- UNKNOWN
- Phase
- NA
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
- Status
- UNKNOWN
- Phase
- N/A
Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
China Ovarian Cancer BRCA Testing Study
- Status
- TERMINATED
- Phase
- N/A
QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A